Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 466
Filter
1.
J Clin Invest ; 52(3): 592-8, 1973 Mar.
Article in English | MEDLINE | ID: mdl-4685083

ABSTRACT

The effectiveness of various antibiotics commonly recommended for the prophylaxis of bacterial endocarditis has been evaluated in experimental streptococcal endocarditis in rabbits. High doses of penicillin G did not prevent the development of this infection. The only consistently successful prophylactic regimens using penicillin alone were those which provided for both an early high serum level and more than 9 h of effective antimicrobial action. Vancomycin was the only other drug which proved uniformly successful when given alone, even though the duration of its antimicrobial action in the blood was only 3 h. However, combined therapy using penicillin G or ampicillin with streptomycin was always effective in prophylaxis. Treatment with single injections of ampicillin, cephaloridine, cephalexin, clindamycin, cotrimoxazole, rifampicin, streptomycin, erythromycin, and tetracycline failed to prevent infection. The findings provide information on the effect of antimicrobials in vivo and may be applicable to the chemoprophylaxis of infective endocarditis in clinical practice.


Subject(s)
Endocarditis, Bacterial/drug therapy , Streptococcal Infections/drug therapy , Ampicillin/blood , Ampicillin/therapeutic use , Animals , Cephaloridine/blood , Cephaloridine/therapeutic use , Clindamycin/blood , Clindamycin/therapeutic use , Erythromycin/blood , Erythromycin/therapeutic use , Female , Male , Penicillin G/blood , Penicillin G/therapeutic use , Rabbits , Rifampin/blood , Rifampin/therapeutic use , Streptomycin/blood , Streptomycin/therapeutic use , Tetracycline/blood , Tetracycline/therapeutic use , Vancomycin/blood , Vancomycin/therapeutic use
2.
J Clin Invest ; 53(3): 829-33, 1974 Mar.
Article in English | MEDLINE | ID: mdl-4492776

ABSTRACT

Bacterial endocarditis was produced by intravenous injection of Streptococcus viridans into rabbits with preexisting sterile endocardial vegetations. After 6 h had elapsed, bacteria in the vegetations could not be eradicated by brief treatment with antimicrobials to which the streptococci were sensitive. However, when treatment with penicillin was continued for 4 days, the animals were cured. The 6-h infection therefore offered a model in which treatments could be conveniently compared over a short period. Synergism was demonstrated between penicillin and streptomycin in endocarditis due to a fully penicillin-sensitive streptococcus, a point which had not been previously proved in vivo. The clinical implications are discussed.


Subject(s)
Endocarditis, Bacterial/drug therapy , Penicillins/therapeutic use , Streptococcal Infections/drug therapy , Streptomycin/therapeutic use , Animals , Anti-Bacterial Agents/pharmacology , Cephaloridine/therapeutic use , Drug Therapy, Combination , Endocarditis, Bacterial/etiology , Erythromycin/therapeutic use , Penicillin G/therapeutic use , Penicillin G Procaine/therapeutic use , Penicillin Resistance , Rabbits , Streptococcal Infections/complications , Streptococcus/drug effects , Swine , Tetracycline/therapeutic use , Vancomycin/therapeutic use
3.
Am J Med ; 71(4): 693-703, 1981 Oct.
Article in English | MEDLINE | ID: mdl-6269429

ABSTRACT

The therapy of gram-negative bacillary meningitis is less than adequate to date; the agents recommended do not achieve bactericidal levels in purulent cerebrospinal fluid. Because optimal antibiotic therapy of meningitis occurs when the cerebrospinal fluid level of an antibiotic is above the concentration needed to kill the offending pathogen, another group of agents needs to be considered. The newer cephalosporins or cehalosporin-type antibiotics (cefotaxime, moxalactam), by virtue of their marked activity against gram-negative bacilli and their ability to achieve significant CSF levels, merit serious consideration as therapy for gram-negative bacillary meningitis. Investigators in Europe and the United States have developed preliminary data demonstrating the efficacy of these agents in a growing number of cases. In the group presented herein, of the 35 cases in which gram-negative bacillary meningitis was treated with the newer cephalosporins, there were only four failures.


Subject(s)
Bacterial Infections/drug therapy , Cephalosporins/therapeutic use , Meningitis/drug therapy , Adolescent , Adult , Aged , Blood-Brain Barrier , Cefamandole/therapeutic use , Cefotaxime/therapeutic use , Cefoxitin/therapeutic use , Cephaloridine/therapeutic use , Cephalosporins/cerebrospinal fluid , Cephalothin/therapeutic use , Cephamycins/therapeutic use , Child, Preschool , Enterobacteriaceae/drug effects , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Moxalactam , Pseudomonas aeruginosa/drug effects
4.
Drugs ; 10(2): 81-111, 1975.
Article in English | MEDLINE | ID: mdl-170053

ABSTRACT

Since the development of the sulphonamides in the 1930s and the subsequent development of antibiotics from the 1940s onwards, there have now been many drugs developed which are capable of chemotherapeutic activity in a patient infected by a susceptible micro-organism. This review is concerned with precise descriptions of important groups of antimicrobial drugs, with emphasis being placed on the more recently developed drugs. With each group of drugs the pharmacology, major therapeutic indications, dosages and adverse reactions are discussed. Part II of the review discusses the cephalosporins, polymyxins and aminoglycosides. The place of each in therapy is defined.


Subject(s)
Anti-Bacterial Agents , Aminoglycosides/therapeutic use , Cephalexin/therapeutic use , Cephaloridine/therapeutic use , Cephalosporins/therapeutic use , Cephalothin/therapeutic use , Cephamycins/therapeutic use , Cephradine/therapeutic use , Framycetin/therapeutic use , Gentamicins/therapeutic use , Humans , Kanamycin/therapeutic use , Neomycin/therapeutic use , Paromomycin/therapeutic use , Polymyxins/therapeutic use , Streptomycin/therapeutic use , Tobramycin/therapeutic use
5.
Arch Ophthalmol ; 93(1): 56-61, 1975 Jan.
Article in English | MEDLINE | ID: mdl-1089403

ABSTRACT

Ocular toxic effects of intravitreal injection of cephaloridine in rabbits was evaluated, and none were produced in doses of 0.25 mg or less. Clinically, intravitreal injection of cephaloridine in doses of 5 mg or more produced small punctate hemorrhages in the vascularized portions of the rabbit retina within two days. With doses of 2.5 mg or less, no clinical changes were seen during the two weeks of observation. Histologically, one day following intravitreal injection of 0.5 to 10 mg of cephaloridine there was clumping of the outer segments of the photoreceptors and destruction of the retinal pigment epithelium. Ten milligrams of cephaloridine intravitreally injected caused definite electroretinogram (ERG) changes ten minutes after injection. After 24 hours, the ERG was extinguished. An experimentally induced Escherichia coli endophthalmitis was successfully treated after six hours by intravitreal injection of cephaloridine.


Subject(s)
Cephaloridine/adverse effects , Endophthalmitis/drug therapy , Retina/drug effects , Animals , Cephaloridine/administration & dosage , Cephaloridine/therapeutic use , Dose-Response Relationship, Drug , Electroretinography , Escherichia coli Infections/drug therapy , Injections/methods , Rabbits , Retina/pathology , Retinal Hemorrhage/chemically induced , Retinal Pigments/drug effects , Time Factors , Vitreous Body
6.
Am J Clin Pathol ; 77(3): 362-3, 1982 Mar.
Article in English | MEDLINE | ID: mdl-7072642

ABSTRACT

We report the first case of endophthalmitis caused by Moraxella nonliquefaciens. Most likely, entry followed minor trauma from a contact lens, with the marked invasiveness of the organism resulting from the patient's immunocompromised state. This case, in addition, serves to illustrate the advantage of genetic transformation assay to differentiate the species of this group of organisms.


Subject(s)
Eye Diseases/microbiology , Moraxella/isolation & purification , Vitreous Body/microbiology , Cephaloridine/therapeutic use , Eye Diseases/drug therapy , Gentamicins/therapeutic use , Humans , Male , Middle Aged , Penicillin G/therapeutic use
7.
J Clin Pathol ; 22(6): 642-3, 1969 Nov.
Article in English | MEDLINE | ID: mdl-5365335

ABSTRACT

Gram-negative septicaemia (Klebsiella) occurred on two occasions in a patient bleeding from an anastomotic ulcer. It is postulated that the presence of this organism in the gut of such a patient provided the portal of entry for this infection.


Subject(s)
Gastroenterostomy , Klebsiella Infections/etiology , Peptic Ulcer Hemorrhage/complications , Postoperative Complications , Sepsis/etiology , Aged , Cephaloridine/therapeutic use , Chloramphenicol/therapeutic use , Humans , Jejunum/microbiology , Klebsiella/isolation & purification , Klebsiella Infections/drug therapy , Male , Peptic Ulcer Hemorrhage/microbiology
8.
J Clin Pathol ; 26(1): 57-9, 1973 Jan.
Article in English | MEDLINE | ID: mdl-4348404

ABSTRACT

Two cases are described in which extensive use was made of the nitroblue tetrazolium (NBT) test. In the first case the advantages of using this technique to diagnose and control infection is shown; in the second the considerable advantage of the speed of the technique. In both of these cases the test made a material contribution to the management of the patient, and it is concluded that the test brings bacteriological control of the patient within the immediate clinical area, thus overcoming one of the principal disadvantages of the classical bacteriological methods.


Subject(s)
Bacterial Infections/therapy , Tetrazolium Salts , Adult , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/diagnosis , Bacteriological Techniques , Bacteriuria/diagnosis , Bacteriuria/drug therapy , Cephaloridine/therapeutic use , Cytomegalovirus Infections/diagnosis , Female , Humans , Male , Methods , Neutrophils , Pregnancy , Sepsis/diagnosis , Sepsis/drug therapy , Serologic Tests , Steroids/therapeutic use , Surgical Wound Infection/diagnosis , Time Factors
9.
Arch Surg ; 118(2): 227-31, 1983 Feb.
Article in English | MEDLINE | ID: mdl-6336937

ABSTRACT

One hundred twenty-three patients undergoing elective colon surgery were prospectively and randomly assigned to receive either three 1-g perioperative doses of intramuscular cephaloridine or three 1-g preoperative doses of both oral erythromycin base and neomycin sulfate. All patients had their bowels thoroughly cleansed mechanically. The groups were comparable in age and nutritional status. Eight wound infections occurred in the 65 patients receiving cephaloridine (12.3%) v one in the 58 receiving erythromycin and neomycin (1.7%). The difference was statistically significant. Eight of nine infected patients had only wound infections; the majority of cultures yielded Bacteroides fragilis. Serum and tissue antimicrobial concentrations were determined in the first 70 randomized patients at operation. Mean (+/- SD) cephaloridine levels were 14.7 +/- 10.2 and 10.5 +/- 10.0 mg/L in serum and tissue, respectively, compared with 1.98 +/- 1.58 and 0.699 +/- 1.146 mg/L for serum and tissue erythromycin levels.


Subject(s)
Cephaloridine/therapeutic use , Colon/surgery , Erythromycin/therapeutic use , Neomycin/therapeutic use , Premedication , Bacteroides Infections/complications , Bacteroides fragilis/isolation & purification , Cephaloridine/administration & dosage , Clinical Trials as Topic , Drug Therapy, Combination , Erythromycin/administration & dosage , Humans , Injections, Intramuscular , Neomycin/administration & dosage , Prospective Studies , Random Allocation , Surgical Wound Infection/etiology
10.
Urology ; 6(5): 535-46, 1975 Nov.
Article in English | MEDLINE | ID: mdl-1103419

ABSTRACT

A comprehensive review of the factors responsible for postoperative wound sepsis is discussed, along with the experimental basis for the use of prophylatic antibiotics and a review of the results of the use of systemic and topical antibiotics on the incidence of surgical wound infections. Based on the data presented, suggestions are made which should minimize the development of postoperative wound infections.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Surgical Wound Infection/etiology , Age Factors , Ampicillin/therapeutic use , Animals , Bacitracin/therapeutic use , Cephaloridine/therapeutic use , Diabetes Complications , Drainage/adverse effects , Gloves, Surgical , Guinea Pigs , Hexachlorophene/therapeutic use , Humans , Intestines/microbiology , Kanamycin/therapeutic use , Length of Stay , Neomycin/therapeutic use , Nutrition Disorders/complications , Obesity/complications , Penicillins/therapeutic use , Staphylococcal Infections/prevention & control , Surgical Wound Infection/prevention & control , Ultraviolet Rays
11.
Urology ; 19(5): 565-9, 1982 May.
Article in English | MEDLINE | ID: mdl-7043860

ABSTRACT

The results of bacterial susceptibility testing in 2,413 urine specimens obtained from patients with urinary tract infections indicated that in a high percentage clinical response could be predicted without the need for antimicrobial sensitivity testing. Simply identifying the infecting organism will provide the clinician with enough information to treat most urinary tract infections intelligently. The relative effectiveness of antimicrobial agents to enable the proper selection of therapy in patients with urinary tract infections is discussed.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests , Urinary Tract Infections/drug therapy , Anti-Bacterial Agents/urine , Bacteria/drug effects , Cephalexin/therapeutic use , Cephaloridine/therapeutic use , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Gentamicins/therapeutic use , Humans , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests/economics , Microbial Sensitivity Tests/methods , Nalidixic Acid/therapeutic use , Proteus mirabilis/drug effects , Pseudomonas/drug effects , Urinary Tract Infections/microbiology , Urinary Tract Infections/urine
12.
Am J Ophthalmol ; 81(1): 52-6, 1976 Jan.
Article in English | MEDLINE | ID: mdl-1082716

ABSTRACT

In our study of 54 suspected cases of endophthalmitis, vitreous aspiration was more sensitive in making a culture-proven diagnosis than anterior chamber paracentesis; Staphylococcus epidermidis was a more common cause of endophthalmitis than previously appreciated; and intraocular antibiotics in the recommended dosage are reasonably safe clinically and add a new dimension to the treatment of endophthalmitis.


Subject(s)
Endophthalmitis/drug therapy , Anterior Chamber/microbiology , Biopsy, Needle , Cephaloridine/therapeutic use , Endophthalmitis/microbiology , Gentamicins/therapeutic use , Humans , Propionibacterium acnes/isolation & purification , Staphylococcus/isolation & purification , Vitreous Body/microbiology
13.
Curr Med Res Opin ; 6(3): 204-6, 1979.
Article in English | MEDLINE | ID: mdl-520026

ABSTRACT

Serum cephaloridine concentrations were measured in the immediate post-operative period in 23 patients who had received a prophylactic dose of 1 g of the drug into the wound at the end of operation. Eleven patients received the antibiotic as a powder and 12 as a solution. The serum concentrations were higher, though not significantly so, in the group receiving powder, and this is thought to be due to the lesser amount of spillage and loss into dressings when the antibiotic is given in this form.


Subject(s)
Cephaloridine/administration & dosage , Surgical Wound Infection/prevention & control , Cephaloridine/blood , Cephaloridine/therapeutic use , Humans , Powders , Solutions , Time Factors
14.
J Hosp Infect ; 4(3): 279-84, 1983 Sep.
Article in English | MEDLINE | ID: mdl-6195240

ABSTRACT

In a series of 236 abdominal operations, patients were allocated at random to receive a single intravenous dose of either 1 g cephaloridine or 1 g latamoxef (at induction of anesthesia) for the prophylaxis of postoperative wound infection. Of the 116 patients given latamoxef, one developed major and seven minor wound infections, whereas five major and 21 minor infections occurred in the cephaloridine group (P less than 0.01). Latamoxef has now replaced cephaloridine as our prophylactic antibiotic of choice in potentially contaminated abdominal operations.


Subject(s)
Abdomen/surgery , Moxalactam/therapeutic use , Surgical Wound Infection/prevention & control , Abdomen/microbiology , Anti-Bacterial Agents/therapeutic use , Cephaloridine/therapeutic use , Clinical Trials as Topic , Humans , Intraoperative Period , Premedication , Random Allocation , Surgical Wound Infection/microbiology
15.
Am J Surg ; 138(5): 640-3, 1979 Nov.
Article in English | MEDLINE | ID: mdl-495848

ABSTRACT

In a prospective study of 107 patients undergoing surgery for gastroduodenal disease, antibiotics were withheld from a group of 24 patients defined preoperatively to be at low risk of developing postoperative infections; no wound infection occurred in this group. Perioperative cephaloridine was randomized among the remaining patients (high risk). Wound infections developed in 11 of 42 patients who did not receive cephaloridine, but in none of the 41 patients who were given cephaloridine (p less than 0.02). Coliform bacteria were grown only from swabs of the stomach mucosa of patients in the high risk group and were the main cause of wound infections. Severe preoperative lymphocytopenia was frequently associated with the development of serious postoperative sepsis. The results validate a policy of restricting antibiotic prophylaxis in gastroduodenal operations to patients at high risk of postoperative infection and suggest a new risk factor--the preoperative blood lymphocyte count.


Subject(s)
Cephaloridine/therapeutic use , Duodenal Ulcer/surgery , Stomach Diseases/surgery , Surgical Wound Infection/prevention & control , Adult , Aged , Humans , Lymphopenia/diagnosis , Middle Aged , Postoperative Complications/prevention & control , Prospective Studies , Random Allocation , Risk
16.
Am J Med Sci ; 269(2): 201-7, 1975.
Article in English | MEDLINE | ID: mdl-1146848

ABSTRACT

Two groups of 38 patients have been treated for staphylococcal infection with either cephaloridine (4 gm daily) or gentamicin (320 mg daily) by the intramuscular route. The rate of favorable clinical response was higher among the patients who received cephaloridine (78.8 per cent) than among those who were treated with gentamicin (60.5 per cent). No death related to the infection occurred in the cephaloridine-treated patients. The mean peak and trough antibacterial activity reached in the serum of the patients after injection of the antibiotics was higher in patients receiving cephaloridine (1/64 and 1/16) than in those treated with gentamicin (1/16 and 1/4). Patients who failed to respond to therapy had often a low antibacterial activity of the serum. These studies suggest that the 1/8 level of bactericidal activity should be attained in the serum one hour after the administration of the antibiotics to allow optimal results in staphylococcal infections.


Subject(s)
Cephaloridine/therapeutic use , Gentamicins/therapeutic use , Staphylococcal Infections/drug therapy , Adult , Aged , Cephaloridine/pharmacology , Female , Gentamicins/pharmacology , Humans , Male , Middle Aged , Staphylococcus/drug effects , Time Factors
17.
J Antibiot (Tokyo) ; 30(11): 983-6, 1977 Nov.
Article in English | MEDLINE | ID: mdl-591464

ABSTRACT

Novobiocin demonstrates an effect similar to that of probenecid (the "probenecid effect") in enhancing the therapeutic efficacy of antibiotics excreted mainly by the renal tubules. The ability of cefoxitin, cephalexin, cephalothin and penicillin G to protect mice against infection with Salmonella schottmuelleri was enhanced 2- to 3-fold when the animals were given oral doses of either probenecid or of novobiocin. The efficacy of cephaloridine, excreted mainly by glomerular filtration, was not enhanced by either probenecid or by novobiocin.


Subject(s)
Cephalosporins/therapeutic use , Novobiocin/pharmacology , Salmonella Infections, Animal/drug therapy , Animals , Cephaloridine/therapeutic use , Drug Interactions , Female , Mice , Penicillin G/therapeutic use , Probenecid/pharmacology
18.
J Pediatr Surg ; 10(1): 43-50, 1975 Feb.
Article in English | MEDLINE | ID: mdl-1090718

ABSTRACT

From a controlled therapeutic trial extending for more than 2 yr and involving 69 patients with appendicitis and peritonitis a clear-cut statistically significant result emerged. There was a major reduction in the incidence of intraperitoneal abscesses using cephaloridine by the intraperitoneal as opposed to the systemic route. After randomized selection into treatment and control groups, cephaloridine, 25 mg/kg was given by injection every 6 hr for 48 hr to the treatment group by i.p. installation and to the control group by systemic injection. Both groups received initial intraoperative peritoneal lavage with normal saline and also continued systemic injections of cephaloridine on postoperative days 3, 4, and 5. Only one out of 36 patients in the treatment group developed a residual intraperitoneal abscess, as opposed to six abscesses developing in 33 patients in the control group. Technical problems and complications of the method were trivial and have not prevented us from continuing and extending the applications of the method.


Subject(s)
Appendectomy , Cephaloridine/administration & dosage , Peritonitis/drug therapy , Postoperative Complications/drug therapy , Administration, Oral , Cephaloridine/therapeutic use , Child , Clinical Trials as Topic , Humans , Injections, Intraperitoneal , Male
19.
J Reprod Med ; 19(2): 51-4, 1977 Aug.
Article in English | MEDLINE | ID: mdl-330851

ABSTRACT

A triple-blind prospective study of women undergoing vaginal hysterectomy was conducted to compare cefazolin, cephaloridine and no antibiotic, Both cefazolin and cephaloridine were given preoperatively, whereas only cephaloridine was given postoperatively. One gram of cefazolin given intramuscularly on call to the operation room was found to be a safe and effective antibiotic for prophylaxis against febrile morbidity. The proper utilization of prophylactic antibiotics seems to be in the immediate preoperative period. The use of antibiotics after the first day of surgery is unnecessary.


PIP: A triple-blind prospective study of 153 women undergoing vaginal hysterectomy between March 1974-February 1975 at Brooke Army Medical Center, was conducted to compare prophylactic antibiotic treatment with nontreatment. The antibiotics studied included cefazolin and cephaloridine. Treated patients received either 1 gm cefazolin on call to the operating room, 3 gm cephaloridine divided into 1 gm doses on call to the operating room, and 1 gm 12 hours later; or were untreated. Febrile morbidity occurred in 7.7% of patients on cefazolin, 12% on cephaloridine, and in 49% of the controls. The predominant organisms recovered were beta hemolytic Streptococcus, group D, intraoperatively and Escherichia coli, postoperatively. The effective use of preoperative prophylaxis is demonstrated.


Subject(s)
Cefazolin/therapeutic use , Cephaloridine/therapeutic use , Cephalosporins/therapeutic use , Hysterectomy, Vaginal , Hysterectomy , Surgical Wound Infection/drug therapy , Adult , Aged , Clinical Trials as Topic , Escherichia coli Infections , Female , Humans , Hysterectomy/adverse effects , Hysterectomy, Vaginal/adverse effects , Middle Aged , Preoperative Care , Prospective Studies , Surgical Wound Infection/etiology
20.
Minerva Med ; 68(57): 3851-8, 1977 Nov 24.
Article in Italian | MEDLINE | ID: mdl-593606

ABSTRACT

A case of bullous pneumopathy in an elderly subject is reported. The particular localization of the pneumonic process at the base of the left lung led to an initial suspicion of diaphragmatic relaxation. Subsequent development and the onset of pneumatoceles within the non-infiltrated pulmonary parenchyma led to a definite diagnosis of bullous pneumopathy which, from its clinico-radiological course, was attributed to a staphylococcic aetiology. Toxic-infective state with leucocytosis and polynucleosis; variability of radiological pictures; early pleural picture; sensitivity to Cephaloridine (which in the present case probably confined the condition to the left lung only); the benign course of the disease; all these elements pointed to staphylococcic bullous pneumopathy in the absence of any cultural demonstration. The different disease conditions in which pneumatoceles occur are reviewed along with the possible mechanisms for their formation.


Subject(s)
Pneumonia/etiology , Staphylococcal Infections , Cephaloridine/therapeutic use , Humans , Male , Middle Aged , Pneumonia/drug therapy , Staphylococcal Infections/drug therapy , Suppuration/etiology
SELECTION OF CITATIONS
SEARCH DETAIL